Leaderboard

En | De
Sie sind hier: Dermatologie » Tumoren » Melanom 30. Januar 2026
Suchen
medline.ch
Melanom
Erweiterte Suche
Dermatologie
Akne
Alopezie
Dermatitis
Infektionen
Photosensitive Erkrankungen
Psoriasis
Tumoren
Melanom
Anderes
Ulcus
Urtikaria
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 2253  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 45055  
   
Clinical Molecular Pathology and Treatment Developments in Advanced Uveal Melanoma: State of the Art.
Oncol Res
Dore S, Sacchi M, Pinna A, Palmieri G, Paliogiannis P.
PMID: 41613812 [PubMed - indexed for MEDLINE]


The Frontier of Melanoma Treatment: Defeating Immunotherapy Resistance-A Systematic Review.
Oncol Res
Mozga K, Synowiecka O, Rydzyk I, Marek A, Wieczorek E, Petniak A, Gil-Kulik P.
PMID: 41613791 [PubMed - indexed for MEDLINE]


Integrating cuproptosis- and ferroptosis-related gene signatures to predict prognosis, immunotherapy response, and drug sensitivity in patients with skin cutaneous melanoma.
Front Immunol
Dong H, Huang Y, Shen J, Ding Z, Wang W, Li Y.
PMID: 41613147 [PubMed - indexed for MEDLINE]


Stereotactic body radiation therapy for oligometastatic melanoma: a real-world study of the ESTRO/EORTC nomenclature.
Radiat Oncol
Heurlin E, Grozman V, Egyhazi Brage S, Lindberg K, Helgadottir H.
PMID: 41612458 [PubMed - as supplied by publisher]


Exogenous Hormone Use and Breslow Thickness in Women With Cutaneous Melanoma: A Retrospective Cohort Study.
Int J Dermatol
Niforou A, Lagiou P, Geller AC, Dessypris N, Stratigos AJ.
PMID: 41612167 [PubMed - as supplied by publisher]


Neoadjuvant PD-1 blockade in surgically resectable desmoplastic melanoma: cohort A of the phase 2 SWOG S1512 trial.
Nat Cancer
Kendra KL, Bellasea SL, Eroglu Z, Hu-Lieskovan S, Campbell KM, Carson WE 3rd, Wada DA, Plaza JA, In GK, Ikeguchi A, Hyngstrom J, Brohl AS, Chmielowski B, Khushalani NI, Markowitz J, Monroe M, Contreras CM, Bowles T, Norman K, Medina E, Gonzalez CR, Baselga-Carretero I, Garcilazo IP, Vega-Crespo A, Chen JM, Deen NNA, Patel SP, Grossmann KF, Sondak VK, Sharon E, Moon J, Wu MC, Ribas A.
PMID: 41611998 [PubMed - as supplied by publisher]


A randomised pilot trial of perioperative propranolol combined with celecoxib versus standard of care in stage III melanoma: The ProCel study protocol.
PLoS One
Selvaraj KJ, Damian DL, Lyons JG, Wilmott JS, Ferguson PM, McGrady M, Bartula I, Lo SN, Scolyer RA, Ferguson AL, Saw RPM.
PMID: 41610103 [PubMed - indexed for MEDLINE]


Long-lasting effects of the COVID-19 pandemic on the incidence and depth of malignant melanoma.
Eur J Dermatol
Possanner C, Spurny-Dworak J, Breier F, Stella A, Feldmann R, Steiner A, Posch C.
PMID: 41608918 [PubMed - indexed for MEDLINE]


Immune landscape of melanoma: Tumor microenvironment, resistance mechanisms, and predictive biomarkers.
World J Clin Oncol
Oliveira MMGL, Lemos CS, Brazão MLS, Rodrigues ALA, do Nascimento EDC, Cardoso EMP, Arantes MFF, de Melo FF.
PMID: 41608340 [PubMed]


Canonical and noncanonical NF-κB signaling in uveal melanoma: mechanisms, microenvironment, and therapeutic modulation.
Med Hypothesis Discov Innov Ophthalmol
Jalali S, Dianat I, Baghi Keshtan S, Izadfar R, Esfandiari HR, Lohrasbi G, Firuzpour F.
PMID: 41608133 [PubMed]


Circulating tumor DNA accelerates diagnosis and treatment guidance for metastatic uveal melanoma with hepatic lesions not amenable to biopsy.
Melanoma Res
Kissinger CR, Miller DJ, Li Z, Ashraf UM, Hubbard G, Wilson MA.
PMID: 41607212 [PubMed - as supplied by publisher]


Treatment effect of neoadjuvant immunotherapy in melanoma correlates with tumor burden: meta-analysis of reported clinical trials.
Melanoma Res
Duarte-Bateman D, Escandón JM, Shen A, Chen Y, Ko J, Melenhorst JJ, Tufaro A, Kennedy LB, Isaacs J, Gastman BR.
PMID: 41607207 [PubMed - as supplied by publisher]


Comment on 'Contrasting Survival Outcomes and Patient Characteristics in 5,815 Patients with Stage II and III Melanoma: A Nationwide Population-Based Registry Study from Sweden'.
Br J Dermatol
Qi J, Nie G.
PMID: 41606788 [PubMed - as supplied by publisher]


Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial.
Nat Med
Duttagupta S, Messaoudene M, Hunter S, Desilets A, Jamal R, Mihalcioiu C, Belkaid W, Marcoux N, Fidelle M, Suissa D, Ponce M, Geiger M, Malo J, Piccinno G, Pun, Filin A, Heidrich V, Rusu D, Mbaye B, Durand S, Ben Aissa I, Puller V, de Lahondès R, Blais N, Tehfe M, Owen S, Bélanger K, Parvathy SN, Shieh B, Raphael J, Lenehan J, Breadner D, Rothenstein J, Rozza N, Maillou J, Nili S, Prifti DK, Pinto F, Armanini F, Kim-Schulze S, Marron TU, Kroemer G, Derosa L, Zitvogel L, Silverman M, Segata N, Vareki SM, Routy B, Elkrief A.
PMID: 41606121 [PubMed - as supplied by publisher]


Neoadjuvant ipilimumab plus nivolumab in melanoma: 5-year survival and biomarker analysis from the phase 2 PRADO-trial.
Nat Med
Hoeijmakers LL, Dimitriadis P, Wijnen SCMA, Reijers ILM, Lopez-Yurda M, Menzies AM, Broeks A, Cornelissen S, Torres Acosta A, van der Wal A, Saw RPM, Versluis JM, van Houdt WJ, Wouters MW, Romano J, Rozeman EA, Grijpink-Ongering LG, Kapiteijn E, van der Veldt AAM, Suijkerbuijk KPM, Eriksson H, Hospers GAP, van der Hage JA, Grünhagen DJ, Witkamp AJ, Lijnsvelt JM, Klop WMC, Zuur CL, Bruining A, Al-Mamgani A, Pennington TE, Shannon KF, Ch'ng S, Colebatch AJ, Gonzalez M, Spillane AJ, Haanen JBAG, Rawson RV, Scolyer RA, van de Wiel BA, van Akkooi ACJ, Long GV, Blank CU.
PMID: 41606118 [PubMed - as supplied by publisher]


Clinical-histological and genetic features of rare variants of melanoma.
Histol Histopathol
Cazzato G, Fortarezza F, Ricci C, Mura MD, Ingravallo G, Dei Tos AP, Barría CW, Kalmykova A, McKee P.
PMID: 41603410 [PubMed - as supplied by publisher]


CAR-T cell immunotherapy of malignant melanoma.
Expert Rev Clin Immunol
Kharasakhal O, Maher J.
PMID: 41601180 [PubMed - as supplied by publisher]


Blocking ASIP to Protect MC1R Signaling and Mitigate Melanoma Risk: An In Silico Study.
Pharmaceuticals (Basel)
Maarfi F, Cherkaoui M, Afreen S, Khan MY.
PMID: 41599712 [PubMed]


Nanotechnology in Cutaneous Oncology: The Role of Liposomes in Targeted Melanoma Therapy.
Molecules
Paulo EPA, Cabral LGS, Poyet JL, Maria DA.
PMID: 41599391 [PubMed - indexed for MEDLINE]


Sentinel Node Biopsy for Head and Neck Melanoma: A 12-Year Experience from a Medium-Volume Regional Center.
J Clin Med
Lázár P, Boa K, Mez, Varga Z, Besenyi Z, Varga E, Németh IB, Baltás E, Oláh J, Kis EG, Piffkó J, Paczona R.
PMID: 41598700 [PubMed]


   
   Artikel 1 - 20 / 45055    Seite 1 von 2253  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1